We are live on ! Find out more

7 hedge funds and large institutions have $79.4K invested in iHuman in 2026 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.11% less ownership

Funds ownership: 0.25% → 0.14% (-0.11%)

13% less funds holding

Funds holding: 8 → 7 (-1)

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

94% less capital inflows, than outflows

Capital inflows: $4.52K | Capital outflows: $81.1K

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
7
Holders Change
-1
Holders Change %
-12.5%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

IH Hedge Fund Activity: Q3 2026 in Review

7 of the 8,114 institutional investors tracked by Wall St. Rank reported a position in iHuman (IH) for Q3 2026, worth a combined $79.4K — down 56% from $180K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of IH and 0 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 1 added.

The largest buyer was Goldman Sachs, adding an estimated $4.52K. The largest seller was Morgan Stanley, cutting an estimated $45.3K.

  • 7 institutional investors held iHuman (IH) as of Q3 2026, down from 8 in Q2 2026.
  • Funds reported $79.4K of iHuman stock for Q3 2026, down 56% quarter-over-quarter.
  • 0 funds opened new iHuman positions in Q3 2026 and 1 closed out, a net change of -1 holder.
  • The largest iHuman buyer in Q3 2026 was Goldman Sachs, an estimated $4.52K added.
  • The largest iHuman seller in Q3 2026 was Morgan Stanley, an estimated $45.3K sold.

Based on aggregated 13F filings for Q3 2026.